Abstract To answer the question as to whether pulmonary rehabilitation programs (PRP) induced increase in exercise tolerance (ET) is associated with increased levels of exhaled nitric oxide (eNO) in COPD patients of di¡erent degrees of severity, we designed a prospective and controlled study. Forty-seven stable COPD patients underwent an 8-week outpatient multidisciplinary PRP including supervised incremental exercise. Fractional eNO concentration (FE NO ) and peak work-rate (W peak ) were assessed baseline (TÀ1), at the end of 1-month run-in period (T0), and after (T1) Cl 0.02, 0.11ppb in mild, moderate and severe patients, respectively). As compared toT0, both W peak (by 17,15 and 10%, respectively) and FE NO (by 29, 24 and 16%, respectively) signi¢cantly increased in all groups, but not in patients with cor pulmonale. A signi¢cant correlation between pre-and post-PRP changes in W peak and FE NO was found both in mild to moderate (r=0.79, Po0.00001) and severe (r=0.76, Po0.001) COPD patients. After a PRP, improvement in ET is associated with an increase in eNO also in most severe COPD patients, but not in those with cor pulmonale. 
INTRODUCTION
Exhaled nitric oxide (eNO) has been proposed as a nonspeci¢c bio-marker in animals and humans (1) . Low eNO levels have been reported in severe chronic obstructive pulmonary disease (COPD) (2) , especially in patients with cor pulmonale (3) .
In healthy subjects, eNO has been shown to be a marker of physical ¢tness (4) . More recently, pulmonary rehabilitation program (PRP) related increase in exercise tolerance (ET) was found to be associated to an increase in eNO in mild-to-moderate COPD patients (5) .
Bene¢ts of PRP have been reported in COPD patients of di¡erent severity (6) . We wondered whether changes in eNO associated with increases in ET might also be observed in most severe COPD patients. Indeed, the recent development of new therapeutical approaches such as lung transplantation and lung volume reduction surgery make severe COPD patients, even those with chronic respiratory failure, candidates for rehabilitation programs (7).
METHODS
The study was approved by the Ethical Committee of Salvatore Maugeri Foundation IRCCS and patients gave their informed consent to participate in the study.
Patients
Forty-seven consecutive, male, stable COPD patients (age 6777 years) referred to a multidisciplinary outpatient PRP at the Pulmonary Rehabilitation unit of S. Maugeri Foundation, Scienti¢c Institute of Gussago, were enrolled. They were divided into three groups according to disease severity as de¢ned by the European Respira- . All patients were ex-smokers and none of them had any history of atopy. At the time of the study, all of them were clinically stable and were receiving their regular treatment with inhaled anticholinergics and rescue short-term-b2-agonists but neither systemic nor inhaled steroids. Seven out of 17 patients in the severe group were on long-term domiciliary oxygen therapy and su¡ered from cor pulmonale as assessed by echocardiography.
Assessment
The study was prospective and controlled, the patients serving as controls of themselves. Measurements of eNO and cycloergometry were performed at T-1, at the end of a 1-month run-in period (T0), and after the completion of PRP (T1). To further assess the clinical e¡ects of PRP, the 6 -min walking distance test (6MWD) (9) and health-related quality of life by means of the St.George Respiratory Questionnaire (SGRQ) (10) were measured at T0 and T1. Data were collected by personnel not involved in the study. Furthermore, physicians evaluating exercise tests were blind to eNO measurements.
Lung function: Static and dynamic lung volumes were measured by means of a constant volume body plethysmograph (Medical Graphic Corp. St. Paul, MN, U.S.A.) with the patient in sitting position according to standard procedure (11) .
Exercise test: Symptom-limited incremental exercise test was performed under EKG monitoring, on an electrically braked cycloergometer (Ergometrics 800S, Sensormedics, Yorba Linda, CA, U.S.A.) using the standard 1-min incremental cycle exercise protocol (10 W each minute) as previously described (5). Mixedexpired gas data, minute ventilation _ V V E , and breathing pattern, were continuously monitored. At rest and at 1-min intervals during exercise, patients were asked their perceived dysponea (D) and sensation of leg fatigue (F ) by pointing to a number or phrase on a 10 -point Borg scale set in large type on a sheet in front of them (12) . . Exhaled NO: Resting exhaled NO was assessed on-line by means of a chemiluminescence analyzer (LR 2000 series, Logan Research, Rochester, U.K.) as recommended and previously described (2, 3, 5, 13) . The mean value of three reproducible (less than 5% within patient variability) readings of eNO plateau (FE NO ) was considered.
Pulmonary Rehabilitation Program
The PRP was a multidisciplinary program consisting of three 3-h sessions per week for 8^10 weeks, including supervised incremental exercise, abdominal, upper and lower limb muscle activities, shoulder and full-arm circling, patient's speci¢c education which has been described elsewhere (5, 14) .
Statistical analysis
All data are shown as mean and standard deviation (SD) or standard error (SE) as speci¢ed. One-way ANOVA for repeated measures was used to test within patients time course of results: post hoc test was then applied when appropriate. Wilcoxon matched paired test was added to test di¡erences for non-parametric measures. Spearman analysis was then used to evaluate the linear correlation coe⁄cient between FE NO and other functional parameters. A P value of less than 0.05 was considered to be statistically signi¢cant.
RESULTS
Characteristics of patients in the study and results are shown inTable1. As expected, baseline ETwas slightly inversely correlated with airway obstruction (FEV 1 vs W peak: r=0.37, P=0.009). No di¡erences in ETwas found between T-1 and T0. After PRP, W peak signi¢cantly increased by 17, 15 and 10% in mild, moderate and severe patients, respectively, whereas the increase in 6MWD was not signi¢cant. The lowest increase in W peak observed in severe patients was mostly due to seven patients with cor pulmonale who did not show any change in ET [from 61 (19) to 62 (24) W at T0 and T1, respectively, mean change (SD): À1.4 (6.9) 95% Cl À1.9 8.1W ], the other 10 severe COPD patients without cor pulmonale, showing a mean14% increase inW peak .
Compared withT-1 and T0, at T1 D and F at the same workload (iso-watts) were signi¢cantly reduced in all groups. SGRQ (total score) signi¢cantly improved by 19, 15 and10% in mild, moderate and severe patients, respectively ( Table 1) .
The mean values of FE NO measured over time are also shown in Table 1 . Resting FE NO assessed at T-1 and T0 were very similar (mean absolute change (SD): 0.03 (0.09) 95% Cl À0.01, 0.16, 0.06 (1.03) 95% Cl 0.03, 0.75 and 0.05 (0.06) 95% Cl 0.02 0.11ppb in mild, moderate and severe patients, respectively). Baseline FE NO was higher in mild and moderate than in severe patients. At T1FE NO signi¢-cantly increased by 29, 24 and 16% in mild, moderate and severe COPD, respectively (Table1).The lowest increase in FE NO observed in severe patients was due to seven COPD patients with cor pulmonale [from 5.2 (0.9) to 5.7 (1.4) ppb at T0 and T1, respectively, mean change (SD): À0.5 (0.8) 95% Cl À0.06 0.91ppb]. The other 10 severe patients without cor pulmonale showed a post-PRP mean increase in FE NO by 22%.
There was signi¢cant correlation between pre-and post-PRP changes in W peak and in FE NO in the whole group (r=0.78, Po0.0001; Fig. 1Fpanel A) as well as in the mild to moderate (r=0.79, Po0.00001; Fig. 1Fpanel  B) and severe (r=0.76, Po0.001; Fig.1Fpanel C) patients. No signi¢cant relationship was observed between changes in FE NO and changes in 6MWD or SGRQ in any group of patients.
DISCUSSION
This study shows that improvement in ET following an outpatient PRP is associated to a parallel increase in resting eNO in COPD patients of di¡erent degrees of severity.This increase is also observed in COPD patients with most severe airway obstruction, but not in those with cor pulmonale.
This study con¢rms that PRP may induce bene¢ts in ET of COPD patients independent of the degree of severity (6) . Nevertheless, severe patients with cor pulmonale in our study did not show such positive results.
In a previous study (5), after a multidisciplinary PRP, mild-to-moderate COPD outpatients showed an increase in eNO correlated with the improvement in ET, thus suggesting FE NO as a marker of physical ¢tness (15) . This study extends those results (5) to severe COPD patients without cor pulmonale. The highly signi¢cant correlation between pre-and post-PRP changes in W peak and in FE NO was independent of airway obstruction (see Fig. 1 ). An indirect evidence of the relationship between ET and FE NO is also given by the fact that patients with cor pulmonale neither gained any bene¢t from PRP, nor showed any increase in eNO (Fig. 1, open  triangles) .
Di¡erent from W peak , no signi¢cant relationship was observed between post-PRP changes in FE NO and 6MWD. This re£ects di¡erences in the modalities of exercise tests, the 6MWD being more related to the endurance capacity than the incremental test. The lack of relationship between changes in eNO and in HRQL is not surprising, probably re£ecting the comprehensive nature of the PRP and the fact that HRQL depends on more than just exercise ability (14) .
In conclusion, this study answered the initial question in that post-PRP improvement in ET is associated to changes in eNO in most severe COPD patients, but not in those with cor pulmonale. What is the relative role of eNO and physical conditioning in these patients must be elucidated by further studies. 
